Clinical Trial: Study of AGN-151586 in Japanese Participants With Moderate to Severe Glabellar Lines
Study Status: COMPLETED
Recruit Status: COMPLETED
Condition: Moderate to Severe Glabellar Lines
Study Type: INTERVENTIONAL
Official Title: A Phase 1/2, Randomized, Double-Blinded, Placebo-Controlled Study of AGN-151586 in the Treatment of Japanese Subjects With Moderate to Severe Glabellar Lines
Brief Summary:
Facial lines that develop from repeated facial expression, such as glabellar lines (GL), are typically treated by selectively weakening specific muscles with small quantities of botulinum toxin.The purpose of this study is to evaluate the safety and efficacy of AGN-151586 over a range of doses for the treatment of moderate to severe GL in Japanese participants.AGN-151586 is an investigational product being developed for the treatment of GL.Participants are randomly assigned to receive AGN-151586 or placebo.There…
Read more